GlassScriptPhysician profile
Samantha Danielle Reckley
NPI 1043085244
$869.07
in general payments reported to CMS, 2019-2025
7 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $609 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $226.61 | 2024 | V.A.C. Veraflo, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Intera Oncology, INC | $208.64 | 2024 | Intera |
| Angiodynamics, INC. | $128.90 | 2025 | Nanoknife |
| E.R. Squibb & Sons, L.L.C. | $117.13 | 2024 | Opdivo |
| Alcresta Therapeutics, INC. | $107.39 | 2025 | Relizorb |
| Glaxosmithkline, LLC. | $56.13 | 2024 | Jemperli |
| Novartis Pharmaceuticals Corporation | $24.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Reckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.